Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 590
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03064867 | Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma | ||
| NCT01652768 | PRESENCE Project: An Early Palliative Care Intervention in Brain Tumors | ||
| NCT04668885 | CPX-351 as a Novel Approach for the Treatment of Older Patients With AML and MDS | ||
| NCT06129747 | Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast | ||
| NCT04187703 | 5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies | ||
| NCT06352866 | Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to tx w/ Teclistamab in RRMM | ||
| NCT03699319 | CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer | ||
| NCT05333029 | Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD | ||
| NCT00428922 | Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients | ||
| NCT00352001 | Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes | ||
| NCT01564914 | A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma | ||
| NCT04187833 | Nivolumab in Combination With Talazoparib in Melanoma and Mutations in BRCA or BRCA-ness Genes | ||
| NCT00281840 | Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | ||
| NCT03150758 | Intra-operative Assessment of Cavernosal Nerve Stimulus Threshold | ||
| NCT02956291 | Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors | ||
| NCT01126450 | Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal Cancer | ||
| NCT01973062 | Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Primary Central Nervous System Non-Hodgkin Lymphoma | ||
| NCT03057613 | The Addition of Pembrolizumab to Postoperative Radiotherapy in Cutaneous Squamous Cell Cancer of the Head and Neck | ||
| NCT03452579 | Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM | ||
| NCT02129569 | Psychoeducational and Behavioral Strategies in Reducing Distress and Anxiety in Patients With Multiple Myeloma and Their Family Caregivers | ||
| NCT05262556 | NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine Carcinomas | ||
| NCT00003953 | Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer | ||
| NCT07225439 | Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL) | ||
| NCT00281801 | Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation | ||
| NCT04013672 | Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence | ||
| NCT02392377 | Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy | ||
| NCT01658319 | Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies | ||
| NCT00305799 | Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors | ||
| NCT01340599 | Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing Surgery | ||
| NCT06150417 | MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA) | ||
| NCT00003917 | Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer | ||
| NCT00003110 | Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma | ||
| NCT04867603 | Digital PET/CT Using [Ga-68]PSMA for Characterization of Prostate Lesions | ||
| NCT01894061 | NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma | ||
| NCT02055586 | FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents | ||
| NCT03799380 | DRIHNC - Dehydration Reduction in Head & Neck Cancer | ||
| NCT04545177 | Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue | ||
| NCT04713241 | Acupuncture for the Treatment of Postoperative Ileus After Gastrointestinal Surgery | ||
| NCT07248228 | Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial) | ||
| NCT00021151 | Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia | ||
| NCT00005642 | SU5416 in Treating Patients With Advanced Solid Tumors | ||
| NCT07117032 | Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain | ||
| NCT06916767 | Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma | ||
| NCT01928485 | Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer | ||
| NCT00608205 | Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck Cancer | ||
| NCT01079832 | Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies | ||
| NCT00873600 | Outpatient Health Care Program for Older Patients Receiving Chemotherapy for Newly Diagnosed Breast Cancer or Colon Cancer | ||
| NCT02794675 | Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Head and Neck Cancer | ||
| NCT07026981 | [Ga-68]MTP220 PET for Biodistribution and Efficacy in Pancreatic Cancer and Head and Neck Cancers | ||
| NCT02762006 | Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma |
